Evidence map›Paper›PMID 36829639›Full record

ReviewBioengineering (Basel, Switzerland)2023

Hemodiafiltration: Technical and Medical Insights.

Thomas Lang, Adam M Zawada, Lukas Theis, Jennifer Braun, Bertram Ottillinger, Pascal Kopperschmidt, Alfred Gagel, Peter Kotanko, Manuela Stauss-Grabo, James P Kennedy and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Effect of online hemodiafiltration on quality of life, fatigue and recovery time: a systematic review and meta-analysis.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Observational
  8. Hemodiafiltration beyond the CONVINCE trial.Clinical kidney journal · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Thomas LangGlobal Biomedical Evidence Generation, Fresenius Medical Care Deutschland GmbH, 61352 Bad Homburg, Germany.
Adam M ZawadaProduct Development, Fresenius Medical Care Deutschland GmbH, 66606 Sankt Wendel, Germany.ORCID 0000-0001-9353-2943
Lukas TheisProduct Development, Fresenius Medical Care Deutschland GmbH, 66606 Sankt Wendel, Germany.
Jennifer BraunGlobal Biomedical Evidence Generation, Fresenius Medical Care Deutschland GmbH, 61352 Bad Homburg, Germany.
Bertram OttillingerOttillinger Life Sciences, 85649 Brunnthal, Germany.ORCID 0000-0002-7901-6165
Pascal KopperschmidtHemodialysis Machines Germany Innovative Technology, Fresenius Medical Care Deutschland GmbH, 97424 Schweinfurt, Germany.
Alfred GagelHemodialysis Machines Global Systems Engineering, Fresenius Medical Care Deutschland GmbH, 97424 Schweinfurt, Germany.ORCID 0000-0002-7573-9833
Peter KotankoRenal Research Institute, New York, NY 10065, USA.
Manuela Stauss-GraboGlobal Biomedical Evidence Generation, Fresenius Medical Care Deutschland GmbH, 61352 Bad Homburg, Germany.
James P KennedyProduct Development, Fresenius Medical Care Deutschland GmbH, 66606 Sankt Wendel, Germany.
Bernard CanaudSchool of Medicine, Montpellier University, 34090 Montpellier, France.ORCID 0000-0001-6854-2816
Fresenius Medical Care (Germany) · DERenal Research Institute · USUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the significant medical and technical improvements in the field of dialytic renal replacement modalities, morbidity and mortality are excessively high among patients with end-stage kidney disease, and most interventional studies yielded disappointing results. Hemodiafiltration, a dialysis method that was implemented in clinics many years ago and that combines the two main principles of hemodialysis and hemofiltration-diffusion and convection-has had a positive impact on mortality rates, especially when delivered in a high-volume mode as a surrogate for a high convective dose. The achievement of high substitution volumes during dialysis treatments does not only depend on patient characteristics but also on the dialyzer (membrane) and the adequately equipped hemodiafiltration machine. The present review article summarizes the technical aspects of online hemodiafiltration and discusses present and ongoing clinical studies with regards to hard clinical and patient-reported outcomes.

Indexed as

convection volumedialysisend-stage kidney diseasehemodiafiltrationperformance

Identifiers

PMID36829639
PMCPMC9952158
OpenAlexW4317811451

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.